Reported side effects have been gastrointestinal symptoms, such as nausea, vomiting, diarrhea, constipation, and abdominal discomfort
Some researchers find the larger injection volumes less comfortable, especially for daily protocols, though retatrutide is administered weekly which makes this less of a concern
however, people with the acquired form do not have mutations in the ADAMTS13 gene
The rate of weight loss with Semaglutide GLP-1 varies from patient to patient and is influenced by factors such as starting weight, dosage, dietary habits, and overall lifestyle
Cannabis doesnt interact with retatrutides metabolism the same way alcohol does, though it can amplify nausea in some people